Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells

Experimental Hematology

Volumn 34, Issue 2, 2006, Pages 197-207

  Hatakeyama, Naoki ^a   Tamura, Yasuaki ^a   Sahara, Hiroeki ^a   Suzuki, Nobuhiro ^a   Suzuki, Kazuhiko ^a   Hori, Tsukasa ^a   Mizue, Nobuo ^a   Torigoe, Toshihiko ^a   Tsutsumi, Hiroyuki ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CASE REPORT; CYTOTOXICITY; DENDRITIC CELL; EPSTEIN BARR VIRUS; FEMALE; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; INFANT; LEUKEMIA CELL LINE; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; T LYMPHOCYTE;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL FUSION; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; EPITOPES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LYMPHOCYTE ACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 31844447852     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.11.004     Document Type: Article

References (29)

1. D.P. Sandler, and J.A. Ross Epidemiology of acute leukemia in children and adults Semin Oncol 24 1997 3 16
2. F.M. Uckun, J.B. Nachman, and H.N. Sather Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group Cancer 83 1998 2030 2039
3. M. Arico, M.G. Valsecchi, and B. Camitta Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia N Engl J Med 342 2000 998 1006
4. F.G. Behm, S.C. Raimondi, and J.L. Frestedt Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age Blood 87 1996 2870 2877
5. J.E. Rubnitz, and W.M. Crist Molecular genetics of childhood cancer: implications for pathogenesis, diagnosis, and treatment Pediatrics 100 1997 101 108
6. M. Schrappe, A. Reiter, and M. Zimmermann Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster Leukemia 14 2000 2205 2222
7. A. Schattenberg, N. Schaap, F. Preijers, R. van der Maazen, and T. de Witte Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients Bone Marrow Transplant 26 2000 17 22
8. H. Dombret, J. Gabert, and J.M. Boiron Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 trial Blood 100 2002 2357 2366
9. V. Brichard, A. Van Pel, and T. Wolfel The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J Exp Med 178 1993 489 495
10. A.B. Bakker, M.W. Schreurs, and A.J. de Boer Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes J Exp Med 179 1994 1005 1009
11. P.G. Coulie, V. Brichard, and A. Van Pel A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J Exp Med 180 1994 35 42
12. R.F. Wang, P.F. Robbins, Y. Kawakami, X.Q. Kang, and S.A. Rosenberg Identification of a gene encoding a melanoma tumor antigen recognized by HLAA31-restricted tumor-infiltrating lymphocytes J Exp Med 181 1995 799 804
13. R.F. Wang, E. Appella, Y. Kawakami, X. Kang, and S.A. Rosenberg Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes J Exp Med 184 1996 2207 2216
14. J. Molldrem, S. Dermime, and K. Parker Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells Blood 88 1996 2450 2457
15. J.J. Molldrem, E. Clave, and Y.Z. Jiang Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units Blood 90 1997 2529 2534
16. H. Ohminami, M. Yasukawa, and S. Fujita HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide Blood 95 2000 286 293
17. H. Dolstra, H. Fredrix, and F. Preijers Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL J Immunol 158 1997 560 565
18. H. Dolstra, H. Fredrix, and F. Maas A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia J Exp Med 189 1999 301 308
19. H. Dolstra, B. de Rijke, and H. Fredrix Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes Eur J Immunol 32 2002 2748 2758
20. B. de Rijke, H. Fredrix, and A. Zoetbrood Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapy Blood 102 2003 2885 2891
21. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
22. M.L. Albert, B. Sauter, and N. Bhardwaj Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 392 1998 86 89
23. F. Henry, O. Boisteau, and L. Bretaudeau Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines Cancer Res 59 1999 3329 3332
24. M. Nouri-Shirazi, J. Banchereau, and D. Bell Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses J Immunol 165 2000 3797 3803
25. L. Fong, and E.G. Engleman Dendritic cells in cancer immunotherapy Annu Rev Immunol 18 2000 245
26. R. Spisek, P. Chevallier, and N. Morineau Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin Cancer Res 62 2002 2861 2868
27. R. Spisek, L. Bretaudeau, I. Barbieux, K. Meflah, and M. Gregoire Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use Cancer Immunol Immunother 50 2001 417 427
28. B. Ludewig, B. Odermatt, A.F. Ochsenbein, R.M. Zinkernagel, and H. Hengartner Role of dendritic cells in the induction and maintenance of autoimmune diseases Immunol Rev 169 1999 45 54
29. B. Ludewig, B. Odermatt, S. Landmann, H. Hengartner, and R.M. Zinkernagel Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue J Exp Med 188 1998 1493 1501